UltraGreen ai (ULG) Q4 2025 earnings summary

Executive summary

• Achieved 24% year-over-year revenue growth to $142.4 million in FY2025, driven by 13% volume growth and a 17% increase in average selling price (ASP).

• Completed IPO in Singapore in December 2025, raising $150 million and ending with a net cash position of $176.1 million.

• Net profit after tax (NPAT) before exceptional items rose 14% to $63.8 million, with reported NPAT up 35% to $75.6 million.

• Divested non-core UltraLinQ business for $23.7 million and acquired remaining interest in PerfusionWorks to enhance data strategy.

• Expanded regulatory approvals and manufacturing capacity to 45 countries, supporting future demand and competitive positioning.

Financial highlights

• Revenue grew 24% year-over-year to $142.4 million; U.S. revenue up 24%, non-U.S. up 41%.

• Gross margin steady at 85%; gross profit up 25% to $121.1 million.

• Adjusted EBITDA up 26% to $89.4 million; margin improved to 62.8%.

• Core net profit after tax (before exceptional items) up 14% to $63.8 million; reported NPAT $75.6 million (+35%).

• Fully diluted EPS post-IPO is $0.07 per share; basic EPS $0.19.

Outlook and guidance

• FY2026 revenue forecasted at $170–190 million, representing 19–33% year-over-year growth.

• Growth expected from core segments, business expansion, pricing initiatives, and new market penetration.

• Continued focus on profitability, disciplined investment, and organizational capability expansion.